Concord Biotech consolidated net profit rises 32.84% in the June 2026 quarter

Sales rise 26.23% to Rs 257.49 crore

Net profit of Concord Biotech rose 32.84% to Rs 58.53 crore in the quarter ended June 2026 as against Rs 44.06 crore during the previous quarter ended June 2025. Sales rose 26.23% to Rs 257.49 crore in the quarter ended June 2026 as against Rs 203.99 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	257.49	203.99	26
OPM %	31.99	30.10	-
PBDT	96.44	76.51	26
PBT	78.34	58.73	33
NP	58.53	44.06	33

Powered by Capital Market - Live News